To date, Neurogen has discovered five candidates that Pfizer has accepted for clinical studies. Neurogen and Pfizer are conducting pre-clinical studies to advance a new candidate in the insomnia program. Neurocrine Biosciences announced today positive test results for its investigational drug NBI-34060 for the treatment of insomnia. Phase I and II studies evaluating NBI-34060 for insomnia in approximately 500 patients. Neurocrine Biosciences is a neuroscience-based research and development biopharmaceutical company focused on the development of therapeutic products.
Insomnia is one of many areas in which the company is working.
The AMA's annual list of resolutions is aimed at reminding all Americans that health care is a partnership between patients and their physicians, and that effective disease prevention begins with a healthy lifestyle. While most Americans have heard these tips before, not everyone is putting them into practice. As these tips suggest, improving your health does not have to be difficult, but people have to be willing to make a commitment to incorporate healthy strategies into their lives. Protect children from violence. Children are not only surrounded by violence in today's society, but too often they are victims.